These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 34228337

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF.
    J Am Coll Cardiol; 2014 Feb 04; 63(4):329-36. PubMed ID: 24140661
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM, Elliott PM.
    Eur Heart J Cardiovasc Imaging; 2018 Jul 01; 19(7):757-767. PubMed ID: 29319785
    [Abstract] [Full Text] [Related]

  • 4. Risk Stratification in Cardiac Sarcoidosis With Cardiac Positron Emission Tomography: A Systematic Review and Meta-Analysis.
    Kafil TS, Shaikh OM, Fanous Y, Benjamen J, Hashmi MM, Jawad A, Dahrouj T, Abazid RM, Swiha M, Romsa J, Beanlands RSB, Ruddy TD, Mielniczuk L, Birnie DH, Tzemos N.
    JACC Cardiovasc Imaging; 2024 Sep 01; 17(9):1079-1097. PubMed ID: 39115497
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on 18F-FDG PET Scans for Suspected Cardiac Sarcoidosis.
    Sperry BW, Tamarappoo BK, Oldan JD, Javed O, Culver DA, Brunken R, Cerqueira MD, Hachamovitch R.
    JACC Cardiovasc Imaging; 2018 Feb 01; 11(2 Pt 2):336-345. PubMed ID: 28823747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia.
    Muser D, Santangeli P, Castro SA, Liang JJ, Enriquez A, Werner TJ, Nucifora G, Magnani S, Hayashi T, Zado ES, Garcia FC, Callans DJ, Dixit S, Desjardins B, Marchlinski FE, Alavi A.
    Eur J Nucl Med Mol Imaging; 2018 Jul 01; 45(8):1394-1404. PubMed ID: 29610956
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY, Carter SV, Flatley E, Ward RP, Moss JD, Appelbaum DE, Singh A, Lang RM, Tung R, Patel AR.
    Int J Cardiovasc Imaging; 2021 Apr 01; 37(4):1361-1369. PubMed ID: 33225427
    [Abstract] [Full Text] [Related]

  • 10. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC.
    JACC Cardiovasc Imaging; 2018 Jan 01; 11(1):94-107. PubMed ID: 28624396
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis.
    Sperry BW, Ibrahim A, Negishi K, Negishi T, Patel P, Popović ZB, Culver D, Brunken R, Marwick TH, Tamarappoo B.
    Am J Cardiol; 2017 May 15; 119(10):1663-1669. PubMed ID: 28343598
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET.
    Yamamoto A, Nagao M, Watanabe E, Imamura Y, Suzuki A, Fukushima K, Ando K, Nakao R, Sakai A, Momose M, Sakai S, Hagiwara N.
    J Nucl Cardiol; 2021 Jun 15; 28(3):919-929. PubMed ID: 33728571
    [Abstract] [Full Text] [Related]

  • 16. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB.
    Eur J Nucl Med Mol Imaging; 2016 Feb 15; 43(2):259-269. PubMed ID: 26359191
    [Abstract] [Full Text] [Related]

  • 17. Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis.
    Bekki M, Tahara N, Tahara A, Sugiyama Y, Maeda-Ogata S, Honda A, Igata S, Enomoto M, Kakuma T, Kaida H, Abe T, Fukumoto Y.
    J Nucl Cardiol; 2022 Oct 15; 29(5):2132-2144. PubMed ID: 34228338
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M, Paudel B, Khalid MU, Ashwath M, Mansour S, Liu K.
    J Nucl Cardiol; 2023 Aug 15; 30(4):1574-1587. PubMed ID: 36443587
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, Baba K, Ishibashi M, Hayabuchi N, Narula J, Imaizumi T.
    JACC Cardiovasc Imaging; 2010 Dec 15; 3(12):1219-28. PubMed ID: 21163450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.